{"name":"Inventprise Inc.","slug":"inventprise-inc","ticker":"","exchange":"","domain":"inventprise.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Prevnar20","genericName":"Prevnar20","slug":"prevnar20","indication":"Other","status":"phase_2"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"PCV 20","genericName":"PCV 20","slug":"pcv-20","indication":"Prevention of invasive pneumococcal disease in adults","status":"phase_3"}]}],"pipeline":[{"name":"Prevnar20","genericName":"Prevnar20","slug":"prevnar20","phase":"phase_2","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"PCV 20","genericName":"PCV 20","slug":"pcv-20","phase":"phase_3","mechanism":"PCV 20 is a pneumococcal conjugate vaccine that stimulates immune responses against 20 serotypes of Streptococcus pneumoniae.","indications":["Prevention of invasive pneumococcal disease in adults","Prevention of pneumococcal pneumonia in adults"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTFB1N2d4NnYwN0JiU181Tm9vV0dUM1c1NWVMUHNCdlZFVmRSZXpmRFp3TnBQUVJXYnFYV1VlNVBIZXU0TzY4bE5BNTd4NGpIT21aYlZHMy1qSW1HWDFH?oc=5","date":"2026-04-06","type":"pipeline","source":"BioSpace","summary":"Layoff Tracker: BioNTech Will Close Singapore Plant, Affecting 85 Employees - BioSpace","headline":"Layoff Tracker: BioNTech Will Close Singapore Plant, Affecting 85 Employees","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE54TU84M2NiREFJa3pSaE1Ick12d3Bva19ndGVZeTBWSks0MldCMW81VlRLQmdSbndMbXpRaFllVDNEaFlQdllfd2ZWQ1JFb3F4YmpDVHRMM3ZxM0dtUXBYWjRUYlNqMXdJblBWSHVvVEplQ0ZETzZuOXdMaE4?oc=5","date":"2026-02-17","type":"pipeline","source":"The New York Times","summary":"Vaccine Makers Curtail Research and Cut Jobs - The New York Times","headline":"Vaccine Makers Curtail Research and Cut Jobs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE9iVUFUYkF6aGt3akxZT0hGaW1LLTVITDlQdFFCYUZkc2IwaDJKSHZpQ1d2VmtPWldraV9yWm9idUZab0xqcWZzdXllQ1BIaF9WUGVxcFJMNWhPakFld2QzRVg2dElTbkZjVjdzcEY3QmtFRG96SzhTT25aMkY?oc=5","date":"2025-12-17","type":"pipeline","source":"Fierce Biotech","summary":"Fierce Biotech Layoff Tracker 2025: Voyager jettisons 30 staffers; Mythic and Areteia shutter - Fierce Biotech","headline":"Fierce Biotech Layoff Tracker 2025: Voyager jettisons 30 staffers; Mythic and Areteia shutter","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE5UNG0xRW9hRXRjWmFPRU0xQ0RLS1FsUFlnQnlUQzdhYVJidHZfSTY2dEVFMEdncVdocUUxVDNBVmJoS1g2bW9TMzlpc3RZTUkzT2xvb0FQc0JKamtuWUpXaG5CYllRdlhFRUJ6R3ZUWUVsZmRoVFJZQTZaZW8?oc=5","date":"2025-01-02","type":"pipeline","source":"Fierce Biotech","summary":"Fierce Biotech Layoff Tracker 2024: Vincerx reduces workforce; Novartis lays off 330 staffers - Fierce Biotech","headline":"Fierce Biotech Layoff Tracker 2024: Vincerx reduces workforce; Novartis lays off 330 staffers","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxNaXMtVzNSd1JKQ3JjZFBMQWxyd1RZME5iYWZ6c05QdDdQZ09abEZsUjdBb2U2XzYyb1FTY3dWOXRMTmRUSnZnTVQ2SmE4UFZpQWY3aVpBdm1hQTVTcER6c1k0M2lKSU5tTUFyU1dtQ1RwNGhBTTF4Q1NhOGlldk54MUlDN0E?oc=5","date":"2024-12-31","type":"pipeline","source":"BioSpace","summary":"Layoffs Continued Across Biopharma in 2024 - BioSpace","headline":"Layoffs Continued Across Biopharma in 2024","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxOUXI2T3VzYTgtZlByV1Z6b2p5QzBDR1g2LTR0YzRVMTYtdjV6RWQ1WVNfX0pzWjRaTThBTElDVk5FamJFVjhERHFmR1FfVzVCN3VKTHBCa0h2Y2dYNkw1cE1jNkZUekNOQXNZc2FtV2VvNTd4LWVwb1BqZkNWOFhiNFRjczludnI2U2JYaE5TQkQtNWRWYXZCa2xtdkJGYXVXeXlrMzhXeWhEQkF6Z3c?oc=5","date":"2024-01-02","type":"trial","source":"Clinical Trials Arena","summary":"Inventprise completes dosing in Phase II pneumococcal vaccine study - Clinical Trials Arena","headline":"Inventprise completes dosing in Phase II pneumococcal vaccine study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxOYWhXdjdpb0xXMXVaZTA1LTROREczZEZQd2FCUWV1b1JvcFVTbVVOM211Und1OGl6SndualRxMmRsMlRlMWZPRTJiQ0dzWThubnJpeUpOVlJRSDBwN2dSNXVfSEY1NnBoZGZHSGhQOTV4QkVUakNRaDNfaXBYWFRhUXppV290bjlfeVFJN09QSnZOQW5TSXQ5VC1UTHAwUzY2d29FYjF3?oc=5","date":"2022-05-10","type":"pipeline","source":"GeekWire","summary":"Bill Gates helps open new vaccine manufacturing facility in Seattle area - GeekWire","headline":"Bill Gates helps open new vaccine manufacturing facility in Seattle area","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAJBVV95cUxPV2MtZzFHX3ZMTVBjMFdxbVM5M21XVmNNVUtnSGhxczdiTWlFV2tHc2FsQnpvUkRVTnRPRVVmVzVGa0hqX1oteEFfTklpN3hQcno5TWdzYTB0dENLOXkzYzUyR1NkYWYzdDBKNzR5WnVfejZDV0pyQ1lhT21aTFRuYnUyOXpTcXpzQ21VOXRhRTZsUmpyNnZYTXVwakNTSzF2X2dhd19KM01tNTZFVTQ2UkhOLUk5RndFeHg0c1dhOHZzUnpWYkZBWkduYTltRTU5TTdtdmo5TTZsRmRxTVlra1pqYk9XdlNiYVlkOUYtYy1tSHh0UnZENjFWTXFWajFUTkV2MW5SVjdmTkJxVUNxWFJIUFVmYUdUakxSLUhWOGFfTGZ2REx4bi0ycUVUbEVmTzBUYWpCRHBBUmZp?oc=5","date":"2021-11-10","type":"trial","source":"businesswire.com","summary":"Inventprise Announces Investment of up to $90 Million to Advance its 25 Valent Pneumococcal Conjugate Vaccine Candidate into Proof-of-Concept Clinical Trials - businesswire.com","headline":"Inventprise Announces Investment of up to $90 Million to Advance its 25 Valent Pneumococcal Conjugate Vaccine Candidate ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxQVFM3WkVBeGZpSEhheTdXVWtzemV5Q0NZY3RQb2d4OTN6X1h6cWxxeHJpQ3pxNldhOS05VF84dkxzYzRGYjYzOTVmc29YOUZVdTc5VS1JRFVTdVZEZkdjODFfaW5seG1POGR5dHBCb0plZ3NCeWpqRWc5MnA4RjZZR2l4QVlFMjg2UU1XR05DXzhMR0hqY0pOMnZibW5LTTlSQTlqb3ZSa3RiRUdU?oc=5","date":"2021-11-10","type":"pipeline","source":"GeekWire","summary":"Seattle-area startup Inventprise gets backing from Gates Foundation for pneumonia shot - GeekWire","headline":"Seattle-area startup Inventprise gets backing from Gates Foundation for pneumonia shot","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_2":1,"phase_3":1},"enrichmentLevel":0,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}